Immunotech Laboratories, Inc.
IMMB · OTC
12/31/2016 | 12/31/2013 | 12/31/2009 | 12/31/2005 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | -$493 | -$626 | – | -$33,595 |
| Dep. & Amort. | $16 | $14 | – | $0 |
| Deferred Tax | $0 | $0 | – | $0 |
| Stock-Based Comp. | $0 | $0 | – | $0 |
| Change in WC | $462 | $314 | – | $146 |
| Other Non-Cash | -$16 | -$14 | – | $33,166 |
| Operating Cash Flow | -$31 | -$312 | – | -$283 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | $0 | -$11 | – | $0 |
| Net Acquisitions | $0 | $14 | – | $0 |
| Inv. Purchases | $0 | $0 | – | $0 |
| Inv. Sales/Matur. | $0 | $0 | – | $0 |
| Other Inv. Act. | $16 | $0 | – | $0 |
| Investing Cash Flow | $16 | $3 | – | $0 |
| Financing Activities | – | – | – | – |
| Debt Repay. | $11 | $0 | – | $0 |
| Stock Issued | $13 | $60 | – | $0 |
| Stock Repurch. | $0 | $0 | – | $0 |
| Dividends Paid | $0 | $0 | – | $0 |
| Other Fin. Act. | $0 | $249 | – | $330 |
| Financing Cash Flow | $24 | $309 | – | $330 |
| Forex Effect | $0 | $0 | – | $0 |
| Net Chg. in Cash | $0 | $0 | – | $47 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $1 | $47 | – | $0 |
| End Cash | $14 | $1 | – | $47 |
| Free Cash Flow | -$31 | -$323 | – | -$283 |